[{"Assets_0_Q2_USD":70459000.0,"CommonStockSharesOutstanding_0_Q2_shares":38476937.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-24706000.0,"NetIncomeLoss_2_Q2_USD":-27569000.0,"NetIncomeLoss_1_Q2_USD":-13804000.0,"StockholdersEquity_0_Q2_USD":45729000.0,"Ticker":"OCUL","CIK":"1393434","name":"OCULAR THERAPEUTIX, INC","OfficialName":"Ocular Therapeutix Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"305481557.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]